KPIs & Operating Metrics(New)
Breakdown Of AssetsCommercial Revenue BreakdownCost Of SalesEmployee StatisticsGross Margin %Gross ProfitIncome Before Provisions For Income TaxesOperating Expense SegregationOpex As A % Of RevenueProfitabilityProfitability %Profitability AnnualProfitability Annual %Property, Plant And Equipment BreakdownRevenue By Business VerticalRevenue By Business Vertical %Revenue By Business Vertical AnnualRevenue By Business Vertical Annual %Revenue By Contracts With CustomerRevenue By Contracts With Customer %Revenue By Countries AnnualRevenue By Countries Annual %Revenue By Customers AnnualRevenue By Customers Annual %Revenue By Timing Of RecognitionRevenue By Timing Of Recognition %Revenue By Timing Of Recognition AnnualRevenue By Timing Of Recognition Annual %Total Revenue Breakdown
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Tax ProvisionsTax Rate
Others
Ratios

BioNTech SE (BNTX) Gross Profit (2018 - 2025)

Historic Gross Profit for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $1.6 billion.

  • BioNTech SE's Gross Profit rose 3688.0% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 billion, marking a year-over-year increase of 515.99%. This contributed to the annual value of $2.4 billion for FY2024, which is 3182.42% down from last year.
  • According to the latest figures from Q3 2025, BioNTech SE's Gross Profit is $1.6 billion, which was up 3688.0% from $208.7 million recorded in Q2 2025.
  • In the past 5 years, BioNTech SE's Gross Profit ranged from a high of $5.8 billion in Q3 2021 and a low of $5.2 million during Q2 2023
  • For the 5-year period, BioNTech SE's Gross Profit averaged around $2.2 billion, with its median value being $1.4 billion (2023).
  • Over the last 5 years, BioNTech SE's Gross Profit had its largest YoY gain of 1330084.73% in 2021, and its largest YoY loss of 9999.84% in 2021.
  • Over the past 5 years, BioNTech SE's Gross Profit (Quarter) stood at $5.7 billion in 2021, then fell by 26.21% to $4.2 billion in 2022, then plummeted by 66.52% to $1.4 billion in 2023, then fell by 27.68% to $1.0 billion in 2024, then skyrocketed by 58.42% to $1.6 billion in 2025.
  • Its Gross Profit was $1.6 billion in Q3 2025, compared to $208.7 million in Q2 2025 and $104.1 million in Q1 2025.